Metformin reverses PARP inhibitors-induced epithelial-mesenchymal transition and PD-L1 upregulation in triple-negative breast cancer.

Please use this identifier to cite or link to this item: http://ir.sinica.edu.tw/handle/201000000A/76429

Title:	Metformin reverses PARP inhibitors-induced epithelial-mesenchymal transition and PD-L1 upregulation in triple-negative breast cancer.
Authors:	Han, Y Li, CW Hsu, JM Hsu, JL Chan, LC Tan, X He, GJ
Issue Date:	2019-04
Relation:	American journal of cancer research 9(4), 800-815
URI:	http://ir.sinica.edu.tw/handle/201000000A/76429
ISSN:	http://gateway.isiknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=Drexel&SrcApp=hagerty_opac&KeyRecord=2156-6976&DestApp=JCR&RQ=IF_CAT_BOXPLOT
URL:	https://www.ncbi.nlm.nih.gov/pubmed/?term=31106005
Appears in Collections:	生物醫學科學研究所

Show full item record

Last Week
0

Last month
0

checked on Jan 4, 2023

Check